Startups

Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Seedtable Score

Score icon 56

Locations

Company Size

  • 51 - 101

Last Stage Round

Insights

LabGenius has significant potential due to its innovative approach combining biopharmaceutical development with advanced machine learning. Located in London and targeting a B2B market, the company uses cutting-edge technology to accelerate the development of protein therapeutics. Traditional protein engineering methods are slow and expensive, leading to higher costs and less effective drugs. By using a machine learning-driven evolution engine, LabGenius can expedite therapeutic development, offering a faster and more cost-effective solution. With backing from Kindred Capital and Atomico, LabGenius is poised to disrupt conventional drug development and establish itself as a market leader.

Total Funding
$83.2M

Investors

Premium Member Intelligence

    Access details of the company management, and other intelligence on this company via Seedtable Intel